CRDF
NASDAQ
$0.84
Cardiff Oncology Inc (CRDF)
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $5.21 (+521.27%)
Market Cap
$85M
Free Cash Flow Yield
-43.83%
Beta (5Y)
1.53
Price Chart
Valuation
Market Cap$85M
P/S175.81
P/B2.50
Profitability
Total Revenue (TTM)$525K
Gross Profit (TTM)-$31M
EBITDA-$47M
Operating Margin-31341%
EPS-$0.66
Financial Health
Free Cash Flow Yield-43.83%
Growth & Risk
EPS 5Y CAGR-0.54%
Revenue 5Y CAGR+7.25%
FCF 5Y CAGR+14.50%
Beta (5Y)1.53
Sharpe Ratio-1.41